Literature DB >> 18631961

Commentary on "a roadmap for the prevention of dementia: the inaugural Leon Thal Symposium." An impending prevention clinical trial for Alzheimer's disease: roadmaps and realities.

Allen D Roses1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18631961     DOI： 10.1016/j.jalz.2008.03.007

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN： 1552-5260            Impact factor:   21.566


× No keyword cloud information.
  5 in total

Review 1.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.

Authors:  Eric M Reiman; Jessica B S Langbaum; Pierre N Tariot
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

3.  Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.

Authors:  Katie Skeehan; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

4.  Anti-Inflammatory, Anti-Diabetic, and Anti-Alzheimer's Effects of Prenylated Flavonoids from Okinawa Propolis: An Investigation by Experimental and Computational Studies.

Authors:  Md Shahinozzaman; Nozomi Taira; Takahiro Ishii; Mohammad A Halim; Md Amzad Hossain; Shinkichi Tawata
Journal:  Molecules       Date:  2018-09-27       Impact factor: 4.411

Review 5.  Mechanisms linking brain insulin resistance to Alzheimer's disease.

Authors:  Maria Niures P S Matioli; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2015 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.